Rubin Bashir, MD
Orthopaedic Surgery of the Spine · Houston, TXNPI 1568653798
Payments from drug & device makers
Across 79 payments — averaging $95.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Alphatec Spine, Inc$2K
- Medacta USA, Inc.$1K
- Providence Medical Technology, Inc.$896
- Si-bone, Inc.$180
- Amplify Surgical, Inc.$145
- plus $594 from 14 others
What the payments were for
- Travel & lodging$3,98553%
- Food & beverage$3,55147%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 23 | $2,443 |
| Alphatec Spine, Inc | 9 | $1,876 |
| Medacta USA, Inc. | 10 | $1,402 |
| Providence Medical Technology, Inc. | 10 | $896 |
| Si-bone, Inc. | 5 | $180 |
| Amplify Surgical, Inc. | 1 | $145 |
| Abbott | 1 | $92 |
| AbbVie | 4 | $74 |
| SK Life Science, Inc. | 2 | $68 |
| Precision Spine, Inc. | 1 | $65 |
| Zimmer Biomet | 2 | $60 |
| Vertex | 2 | $59 |
| Amgen | 2 | $41 |
| Lundbeck LLC | 1 | $31 |
| ERMI LLC | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Intrinsic Therapeutics | 1 | $17 |
| Harmony Biosciences LLC | 1 | $17 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Other - Miscellaneous$1,641
- AMISTEM$902
- CASCADIA INTERBODY SYSTEM$721
- TRITANIUM$520
- GMK SPHERE$460
- EVEREST SPINAL SYSTEM$364
- CAPRI CORPECTOMY CAGE SYSTEM$164
- dualX$145
- AVS ANCHOR-L$106
How this compares
$7,536 in reported general payments places this provider in the 35th percentile of 207 orthopaedic surgery of the spine providers in Texas.
See all orthopaedic surgery of the spine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 44 | $262 |
| Pregabalin | 12 | $244 |
| Gabapentin | 22 | $206 |
| Tramadol Hcl | 17 | $114 |
| Cyclobenzaprine Hcl | 15 | $104 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Houston
- David WimberleyHouston$2.2M
- Shah-Nawaz DodwadHouston$710K
- Leonard KibuuleHouston$669K
- Vivek KushwahaHouston$632K
- Robert MohrHouston$352K
- Bernhard MeyerHouston$238K
- Ra'kerry RahmanHouston$188K
- Ryan StuckeyHouston$181K
- Rex MarcoHouston$174K
- Richard FrancisHouston$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.